{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T06:32:49Z","timestamp":1793082769265,"version":"4.5.0"},"reference-count":59,"publisher":"Elsevier BV","issue":"1","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CMP"],"published-print":{"date-parts":[[2020,12,31]]},"abstract":"<jats:sec>\n<jats:title>Background:<\/jats:title>\n<jats:p>Central nervous system disorders such as anxiety, depression and epilepsy are characterized by sharing several\nmolecular mechanisms in common and the involvement of the L-arginine\/NO pathway in neurobehavioral studies with \u03b2-caryophyllene is\nstill little discussed.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Objectives:<\/jats:title>\n<jats:p> One of the objectives of the present study was to demonstrate the anxiolytic behavioral effect of \u03b2-caryophyllene (\u03b2-CBP) in\nfemale Swiss mice, as well as to investigate the molecular mechanisms underlying the results obtained.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Methods:<\/jats:title>\n<jats:p>This study evaluated the neurobehavioral effects of \u03b2-CBP using the open field test, rota-rod test, elevated plus maze test, novelty\nsuppressed feeding test, tail suspension test and forced swim test, as well as pilocarpine, pentylenetetrazole and isoniazid-induced epileptic\nseizure models.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Results::<\/jats:title>\n<jats:p>The results demonstrated that the neuropharmacological activities of \u03b2-CBP may involve benzodiazepine\/GABAergic receptors,\nsince the pre-treatment of \u03b2-CBP (200 mg\/kg) associated with flumazenil (5 mg\/kg, benzodiazepine receptor antagonist) and bicuculline (1\nmg\/kg, selective GABAA receptor antagonist) reestablished the anxiety parameters in the elevated plus-maze test, as well as the results of\nreduced latency to consume food in the novelty suppressed feeding test. In addition to benzodiazepine\/GABAergic receptors, the\nneuropharmacological properties of \u03b2-CBP may be related to inhibition of nitric oxide synthesis, since pre-treatment with L-arginine (500-\n750 mg\/kg) reversed significantly the anxiolytic, antidepressant and anticonvulsant activities of \u03b2-CBP.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Conclusion:<\/jats:title>\n<jats:p>The results obtained provide additional support in understanding the neuromolecular mechanisms underlying the anxiolytic,\nantidepressant and anticonvulsive properties of \u03b2-CBP in female Swiss mice.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/1874467213666200510004622","type":"journal-article","created":{"date-parts":[[2020,5,10]],"date-time":"2020-05-10T06:10:38Z","timestamp":1589091038000},"page":"36-51","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["Anticonvulsant, Anxiolytic and Antidepressant Properties of the \u03b2-caryophyllene in Swiss Mice: Involvement of Benzodiazepine-GABAAergic, Serotonergic and Nitrergic Systems"],"prefix":"10.1016","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6901-2526","authenticated-orcid":true,"given":"George L.","family":"da Silva Oliveira","sequence":"first","affiliation":[{"name":"Department of Biology, Federal Institute of Mato Grosso, Guaranta do Norte - MT, 78520-000, Guaranta do Norte Campus, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 C. Correia L.","family":"da Silva","sequence":"additional","affiliation":[{"name":"Department of Computer Science, Federal University of Piaui, Teresina, 64049-550, Piaui, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2918-5179","authenticated-orcid":true,"given":"Ana P.","family":"dos Santos C. L da Silva","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Federal University of Piaui, 64049-550, Teresina, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8013-1761","authenticated-orcid":true,"given":"Chistiane M.","family":"Feitosa","sequence":"additional","affiliation":[{"name":"Department of Chemistry, University Federal of Piaui, 64049-550, Teresina, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4653-027X","authenticated-orcid":true,"given":"Fernanda R.","family":"de Castro Almeida","sequence":"additional","affiliation":[{"name":"Center for Research on Medicinal Plants, Federal University of Piaui, 64049-550 Teresina, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"9099","DOI":"10.1073\/pnas.0803601105","volume":"105","author":"Gertsch J.","year":"2008","unstructured":"Gertsch J.; Leonti M.; Raduner S.; Racz I.; Chen J.Z.; Xie X.Q.; Altmann K.H.; Karsak M.; Zimmer A.; Beta-caryophyllene is a dietary cannabinoid. Proc Natl Acad Sci USA 2008,105(26),9099-9104","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"4109","DOI":"10.1007\/978-3-642-22144-6_183","author":"Buchbauer G.","year":"2013","unstructured":"Buchbauer G.; Llic A.;  Natural Products: Phytochemistry, Botany and Metabolism of Alkaloids, Phenolics and Terpenes 2013,4109-4159","journal-title":"Natural Products: Phytochemistry, Botany and Metabolism of Alkaloids, Phenolics and Terpenes"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"15864","DOI":"10.1021\/ie301294f","volume":"49","author":"Yang G.","year":"2012","unstructured":"Yang G.; Wu P.; Zhou Z.; He X.; Meng W.; Zhang Z.; Direct Hydration of \u03b2-Caryophyllene. Ind Eng Chem Res 2012,49,15864-15871","journal-title":"Ind Eng Chem Res"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1016\/j.indcrop.2012.09.010","volume":"44","author":"Almeida T.S.","year":"2013","unstructured":"Almeida T.S.; Rocha J.B.T.; Rodrigues F.F.G.; Campos A.R.; Costa J.G.M.; Chemical composition, antibacterial and antibiotic modulatory effect of Croton campestris essential oils. Ind Crops Prod 2013,44,630-633","journal-title":"Ind Crops Prod"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1016\/j.yrtph.2017.12.013","volume":"92","author":"Oliveira G.L.D.S.","year":"2018","unstructured":"Oliveira G.L.D.S.; Machado K.C.; Machado K.C.; da Silva A.P.D.S.C.L.; Feitosa C.M.; de Castro Almeida F.R.; Non-clinical toxicity of \u03b2-caryophyllene, a dietary cannabinoid: Absence of adverse effects in female Swiss mice. Regul Toxicol Pharmacol 2018,92,338-346","journal-title":"Regul Toxicol Pharmacol"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.neuropharm.2017.07.015","volume":"125","author":"Segat G.C.","year":"2017","unstructured":"Segat G.C.; Manjavachi M.N.; Matias D.O.; Passos G.F.; Freitas C.S.; Costa R.; Calixto J.B.; Antiallodynic effect of \u03b2-caryophyllene on paclitaxel-induced peripheral neuropathy in mice. Neuropharmacology 2017,125,207-219","journal-title":"Neuropharmacology"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1016\/j.pbb.2014.06.025","volume":"124","author":"Al Mansouri S.","year":"2014","unstructured":"Al Mansouri S.; Ojha S.; Al Maamari E.; Al Ameri M.; Nurulain S.M.; Bahi A.; The cannabinoid receptor 2 agonist, \u03b2-caryophyllene, reduced voluntary alcohol intake and attenuated ethanol-induced place preference and sensitivity in mice. Pharmacol Biochem Behav 2014,124,260-268","journal-title":"Pharmacol Biochem Behav"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"2228","DOI":"10.1002\/mnfr.201600197","volume":"60","author":"Kamikubo R.","year":"2016","unstructured":"Kamikubo R.; Kai K.; Tsuji-Naito K.; Akagawa M.; \u03b2-Caryophyllene attenuates palmitate-induced lipid accumulation through AMPK signaling by activating CB2 receptor in human HepG2 hepatocytes. Mol Nutr Food Res 2016,60(10),2228-2242","journal-title":"Mol Nutr Food Res"},{"key":"ref=9","first-page":"1","volume":"2","author":"Baldissera M.D.","year":"2016","unstructured":"Baldissera M.D.; Souza C.F.; Grando T.H.; Doleski P.H.; Boligon A.A.; Stefani L.M.; Monteiro S.G.; Hypolipidemic effect of \u03b2-caryophyllene to treat hyperlipidemic rats. Naunyn Schmiedebergs Arch Pharmacol 2016,2,1-9","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.biopha.2017.04.092","volume":"91","author":"Fontes L.B.A.","year":"2017","unstructured":"Fontes L.B.A.; Dias D.D.S.; Aarestrup B.J.V.; Aarestrup F.M.; Da Silva Filho A.A.; Corr\u00eaa J.O.D.A.; \u03b2-Caryophyllene ameliorates the development of experimental autoimmune encephalomyelitis in C57BL\/6 mice. Biomed Pharmacother 2017,91,257-264","journal-title":"Biomed Pharmacother"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.cbi.2015.12.019","volume":"245","author":"Basha R.H.","year":"2016","unstructured":"Basha R.H.; Sankaranarayanan C.; \u03b2-Caryophyllene, a natural sesquiterpene lactone attenuates hyperglycemia mediated oxidative and inflammatory stress in experimental diabetic rats. Chem Biol Interact 2016,245,50-58","journal-title":"Chem Biol Interact"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.intimp.2017.07.009","volume":"51","author":"Hu Y.","year":"2017","unstructured":"Hu Y.; Zeng Z.; Wang B.; Guo S.; Trans-caryophyllene inhibits amyloid \u03b2 (A\u03b2) oligomer-induced neuroinflammation in BV-2 microglial cells. Int Immunopharmacol 2017,51,91-98","journal-title":"Int Immunopharmacol"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.physbeh.2014.06.003","volume":"135","author":"Bahi A.","year":"2014","unstructured":"Bahi A.; Al Mansouri S.; Al Memari E.; Al Ameri M.; Nurulain S.M.; Ojha S.; \u03b2-Caryophyllene, a CB2 receptor agonist produces multiple behavioral changes relevant to anxiety and depression in mice. Physiol Behav 2014,135,119-124","journal-title":"Physiol Behav"},{"key":"ref=14","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbr.2019.112439","volume":"380","author":"Hwang E.S.","year":"2020","unstructured":"Hwang E.S.; Kim H.B.; Lee S.; Kim M.J.; Kim K.J.; Han G.; Han S.Y.; Lee E.A.; Yoon J.H.; Kim D.O.; Maeng S.; Park J.H.; Antidepressant-like effects of \u03b2-caryophyllene on restraint plus stress-induced depression. Behav Brain Res 2020,380","journal-title":"Behav Brain Res"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1016\/j.neuroscience.2014.08.043","volume":"279","author":"Assis L.C.","year":"2014","unstructured":"Assis L.C.; Straliotto M.R.; Engel D.; Hort M.A.; Dutra R.C.; de Bem A.F.; \u03b2-Caryophyllene protects the C6 glioma cells against glutamate-induced excitotoxicity through the Nrf2 pathway. Neuroscience 2014,279,220-231","journal-title":"Neuroscience"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.yebeh.2015.12.040","volume":"56","author":"de Oliveira C.C.","year":"2016","unstructured":"de Oliveira C.C.; de Oliveira C.V.; Grigoletto J.; Ribeiro L.R.; Funck V.R.; Grauncke A.C.B.; de Souza T.L.; Souto N.S.; Furian A.F.; Menezes I.R.; Oliveira M.S.; Anticonvulsant activity of \u03b2-caryophyllene against pentylenetetrazol-induced seizures. Epilepsy Behav 2016,56,26-31","journal-title":"Epilepsy Behav"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000362689","volume":"94","author":"Cheng Y.","year":"2014","unstructured":"Cheng Y.; Dong Z.; Liu S.; \u03b2-Caryophyllene ameliorates the Alzheimer-like phenotype in APP\/PS1 Mice through CB2 receptor activation and the PPAR\u03b3 pathway. Pharmacology 2014,94(1-2),1-12","journal-title":"Pharmacology"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1007\/s11010-016-2733-y","volume":"418","author":"Ojha S.","year":"2016","unstructured":"Ojha S.; Javed H.; Azimullah S.; Haque M.E.; \u03b2-Caryophyllene, a phytocannabinoid attenuates oxidative stress, neuroinflammation, glial activation, and salvages dopaminergic neurons in a rat model of Parkinson disease. Mol Cell Biochem 2016,418(1-2),59-70","journal-title":"Mol Cell Biochem"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.gene.2017.04.048","volume":"625","author":"Bruenig D.","year":"2017","unstructured":"Bruenig D.; Morris C.P.; Mehta D.; Harvey W.; Lawford B.; Young R.M.; Voisey J.; Nitric oxide pathway genes (NOS1AP and NOS1) are involved in PTSD severity, depression, anxiety, stress and resilience. Gene 2017,625,42-48","journal-title":"Gene"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"2857","DOI":"10.1038\/npp.2014.137","volume":"39","author":"Sarginson J.E.","year":"2014","unstructured":"Sarginson J.E.; Deakin J.F.W.; Anderson I.M.; Downey D.; Thomas E.; Elliott R.; Juhasz G.; Neuronal nitric oxide synthase (NOS1) polymorphisms interact with financial hardship to affect depression risk. Neuropsychopharmacology 2014,39(12),2857-2866","journal-title":"Neuropsychopharmacology"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.neuropharm.2011.08.040","volume":"62","author":"M\u00f6hler H.","year":"2012","unstructured":"M\u00f6hler H.; The GABA system in anxiety and depression and its therapeutic potential. Neuropharmacology 2012,62(1),42-53","journal-title":"Neuropharmacology"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.lfs.2018.08.050","volume":"210","author":"\u017bmudzka E.","year":"2018","unstructured":"\u017bmudzka E.; Sa\u0142aciak K.; Sapa J.; Pytka K.; Serotonin receptors in depression and anxiety: Insights from animal studies. Life Sci 2018,210,106-124","journal-title":"Life Sci"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.cbi.2015.10.003","volume":"242","author":"Machado K.C.","year":"2015","unstructured":"Machado K.C.; Oliveira G.L.S.; Machado K.C.; Islam M.T.; Junior A.L.G.; De Sousa D.P.; Freitas R.M.; Anticonvulsant and behavioral effects observed in mice following treatment with an ester derivative of ferulic acid: Isopentyl ferulate. Chem Biol Interact 2015,242,273-279","journal-title":"Chem Biol Interact"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1038\/nprot.2006.20","volume":"1","author":"Deacon R.M.J.","year":"2006","unstructured":"Deacon R.M.J.; Digging and marble burying in mice: simple methods for in vivo identification of biological impacts. Nat Protoc 2006,1(1),122-124","journal-title":"Nat Protoc"},{"key":"ref=25","first-page":"1002","volume":"253","author":"Onaivi E.S.","year":"1990","unstructured":"Onaivi E.S.; Green M.R.; Martin B.R.; Pharmacological characterization of cannabinoids in the elevated plus maze. J Pharmacol Exp Ther 1990,253(3),1002-1009","journal-title":"J Pharmacol Exp Ther"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1126\/science.1083328","volume":"301","author":"Santarelli L.","year":"2003","unstructured":"Santarelli L.; Saxe M.; Gross C.; Surget A.; Battaglia F.; Dulawa S.; Weisstaub N.; Lee J.; Duman R.; Arancio O.; Belzung C.; Hen R.; Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants. Science 2003,301(5634),805-809","journal-title":"Science"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1016\/0278-5846(87)90002-9","volume":"11","author":"Steru L.","year":"1987","unstructured":"Steru L.; Chermat R.; Thierry B.; Mico J.A.; Lenegre A.; Steru M.; Simon P.; Porsolt R.D.; The automated Tail Suspension Test: a computerized device which differentiates psychotropic drugs. Prog Neuropsychopharmacol Biol Psychiatry 1987,11(6),659-671","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1016\/0014-2999(78)90118-8","volume":"47","author":"Porsolt R.D.","year":"1978","unstructured":"Porsolt R.D.; Anton G.; Blavet N.; Jalfre M.; Behavioural despair in rats: a new model sensitive to antidepressant treatments. Eur J Pharmacol 1978,47(4),379-391","journal-title":"Eur J Pharmacol"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/j.physbeh.2004.01.013","volume":"81","author":"Ducottet C.","year":"2004","unstructured":"Ducottet C.; Belzung C.; Behaviour in the elevated plus-maze predicts coping after subchronic mild stress in mice. Physiol Behav 2004,81(3),417-426","journal-title":"Physiol Behav"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1016\/j.pnpbp.2012.04.012","volume":"38","author":"Galdino P.M.","year":"2012","unstructured":"Galdino P.M.; Nascimento M.V.M.; Florentino I.F.; Lino R.C.; Fajemiroye J.O.; Chaibub B.A.; de Paula J.R.; de Lima T.C.; Costa E.A.; The anxiolytic-like effect of an essential oil derived from Spiranthera odoratissima A. St. Hil. leaves and its major component, \u03b2-caryophyllene, in male mice. Prog Neuropsychopharmacol Biol Psychiatry 2012,38(2),276-284","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1016\/0031-9384(94)90090-6","volume":"55","author":"Par\u00e9 W.P.","year":"1994","unstructured":"Par\u00e9 W.P.; Hyponeophagia in Wistar Kyoto (WKY) rats. Physiol Behav 1994,55(5),975-978","journal-title":"Physiol Behav"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/0166-4328(94)90008-6","volume":"61","author":"Simon P.","year":"1994","unstructured":"Simon P.; Dupuis R.; Costentin J.; Thigmotaxis as an index of anxiety in mice. Influence of dopaminergic transmissions. Behav Brain Res 1994,61(1),59-64","journal-title":"Behav Brain Res"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1016\/0091-3057(88)90413-3","volume":"31","author":"Treit D.","year":"1988","unstructured":"Treit D.; Fundytus M.; Thigmotaxis as a test for anxiolytic activity in rats. Pharmacol Biochem Behav 1988,31(4),959-962","journal-title":"Pharmacol Biochem Behav"},{"key":"ref=34","year":"2013","unstructured":"Diagnostic and Statistical Manual of Mental Disorders American Psychiatric Association (APS)2013","journal-title":"Diagnostic and Statistical Manual of Mental Disorders"},{"key":"ref=35","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/B978-0-12-804066-9.00039-0","author":"Auvin S.","year":"2017","unstructured":"Auvin S.; NEHLIG A.;  Models of Seizures and Epilepsy (Second edition) 2017,569-586","journal-title":"Models of Seizures and Epilepsy (Second edition)"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1007\/s11064-014-1474-0","volume":"40","author":"Liu H.","year":"2015","unstructured":"Liu H.; Song Z.; Liao D.; Zhang T.; Liu F.; Zhuang K.; Luo K.; Yang L.; Neuroprotective effects of trans-caryophyllene against kainic acid induced seizure activity and oxidative stress in mice. Neurochem Res 2015,40(1),118-123","journal-title":"Neurochem Res"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"15498","DOI":"10.1038\/s41598-017-15628-7","volume":"7","author":"Wongsamitkul N.","year":"2017","unstructured":"Wongsamitkul N.; Maldifassi M.C.; Simeone X.; Baur R.; Ernst M.; Sigel E.; \u03b1 subunits in GABA receptors are dispensable for GABA and diazepam action. Sci Rep 2017,7(1),15498","journal-title":"Sci Rep"},{"key":"ref=38","doi-asserted-by":"publisher","DOI":"10.1177\/2398212819858249","volume":"3","author":"Smart T.G.","year":"2019","unstructured":"Smart T.G.; Stephenson F.A.; A half century of \u03b3-aminobutyric acid. Brain Neurosci Adv 2019,3","journal-title":"Brain Neurosci Adv"},{"key":"ref=39","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/S1054-3589(10)58016-5","volume":"58","author":"Cryan J.F.","year":"2010","unstructured":"Cryan J.F.; Slattery D.A.;  Advances in Pharmacology 2010,58,427-451","journal-title":"Advances in Pharmacology"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.neuropharm.2018.01.036","volume":"136","author":"Olsen R.W.","year":"2018","unstructured":"Olsen R.W.; GABA receptor: Positive and negative allosteric modulators. Neuropharmacology 2018,136(Pt A),10-22","journal-title":"Neuropharmacology"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1002\/mnfr.201300420","volume":"58","author":"Kessler A.","year":"2014","unstructured":"Kessler A.; Sahin-Nadeem H.; Lummis S.C.; Weigel I.; Pischetsrieder M.; Buettner A.; Villmann C.; GABA(A) receptor modulation by terpenoids from Sideritis extracts. Mol Nutr Food Res 2014,58(4),851-862","journal-title":"Mol Nutr Food Res"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1016\/j.ajpath.2010.11.052","volume":"178","author":"Bento A.F.","year":"2011","unstructured":"Bento A.F.; Marcon R.; Dutra R.C.; Claudino R.F.; Cola M.; Leite D.F.; Calixto J.B.; \u03b2-Caryophyllene inhibits dextran sulfate sodium-induced colitis in mice through CB2 receptor activation and PPAR\u03b3 pathway. Am J Pathol 2011,178(3),1153-1166","journal-title":"Am J Pathol"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.neulet.2014.12.003","volume":"587","author":"Garc\u00eda M.C.","year":"2015","unstructured":"Garc\u00eda M.C.; Cinquina V.; Palomo-Garo C.; R\u00e1bano A.; Fern\u00e1ndez-Ruiz J.; Identification of CB\u2082 receptors in human nigral neurons that degenerate in Parkinson\u2019s disease. Neurosci Lett 2015,587,1-4","journal-title":"Neurosci Lett"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"321","DOI":"10.3389\/fnins.2016.00321","volume":"10","author":"Javed H.","year":"2016","unstructured":"Javed H.; Azimullah S.; Haque M.E.; Ojha S.K.; Cannabinoid Type 2 (CB2) Receptors Activation Protects against Oxidative Stress and Neuroinflammation Associated Dopaminergic Neurodegeneration in Rotenone Model of Parkinson\u2019s Disease. Front Neurosci 2016,10,321","journal-title":"Front Neurosci"},{"key":"ref=45","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/bs.apha.2014.10.002","volume":"72","author":"Sieghart W.","year":"2015","unstructured":"Sieghart W.;  Advances in Pharmacology 2015,72,53-96","journal-title":"Advances in Pharmacology"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"E5007","DOI":"10.1073\/pnas.1413210111","volume":"111","author":"Zhang H.Y.","year":"2014","unstructured":"Zhang H.Y.; Gao M.; Liu Q.R.; Bi G.H.; Li X.; Yang H.J.; Gardner E.L.; Wu J.; Xi Z.X.; Cannabinoid CB2 receptors modulate midbrain dopamine neuronal activity and dopamine-related behavior in mice. Proc Natl Acad Sci USA 2014,111(46),E5007-E5015","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/S0014-2999(02)02331-2","volume":"452","author":"Wallace M.J.","year":"2002","unstructured":"Wallace M.J.; Martin B.R.; DeLorenzo R.J.; Evidence for a physiological role of endocannabinoids in the modulation of seizure threshold and severity. Eur J Pharmacol 2002,452(3),295-301","journal-title":"Eur J Pharmacol"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1124\/jpet.103.051920","volume":"307","author":"Wallace M.J.","year":"2003","unstructured":"Wallace M.J.; Blair R.E.; Falenski K.W.; Martin B.R.; DeLorenzo R.J.; The endogenous cannabinoid system regulates seizure frequency and duration in a model of temporal lobe epilepsy. J Pharmacol Exp Ther 2003,307(1),129-137","journal-title":"J Pharmacol Exp Ther"},{"key":"ref=49","first-page":"27","author":"Ramirez-Mahaluf J.P.","year":"2018","unstructured":"Ramirez-Mahaluf J.P.; Compte A.;  Computational Psychiatry 2018,27-46","journal-title":"Computational Psychiatry"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"309","DOI":"10.2174\/1871527317666180420150249","volume":"17","author":"de Oliveira D.R.","year":"2018","unstructured":"de Oliveira D.R.; da Silva D.M.; Florentino I.F.; de Brito A.F.; Fajemiroye J.O.; da Silva D.P.B.; da Rocha F.F.; Costa E.A.; Galdino P.M.; Monoamine Involvement in the Antidepressant-Like Effect of \u03b2-Caryophyllene. CNS Neurol Disord Drug Targets 2018,17(4),309-320","journal-title":"CNS Neurol Disord Drug Targets"},{"key":"ref=51","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/j.ejphar.2011.11.009","volume":"674","author":"Gon\u00e7alves A.E.","year":"2012","unstructured":"Gon\u00e7alves A.E.; B\u00fcrger C.; Amoah S.K.S.; Tolardo R.; Biavatti M.W.; de Souza M.M.; The antidepressant-like effect of Hedyosmum brasiliense and its sesquiterpene lactone, podoandin in mice: evidence for the involvement of adrenergic, dopaminergic and serotonergic systems. Eur J Pharmacol 2012,674(2-3),307-314","journal-title":"Eur J Pharmacol"},{"key":"ref=52","first-page":"127","volume":"96","author":"Hu Y.","year":"2014","unstructured":"Hu Y.; Zhu D.Y.;  Vitamins  2014,96,127-160","journal-title":"Vitamins"},{"key":"ref=53","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1089\/jmf.2012.2283","volume":"16","author":"Chang H.J.","year":"2013","unstructured":"Chang H.J.; Kim J.M.; Lee J.C.; Kim W.K.; Chun H.S.; Protective effect of \u03b2-caryophyllene, a natural bicyclic sesquiterpene, against cerebral ischemic injury. J Med Food 2013,16(6),471-480","journal-title":"J Med Food"},{"key":"ref=54","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.yebeh.2017.08.039","volume":"76","author":"Chen B.","year":"2017","unstructured":"Chen B.; Choi H.; Hirsch L.J.; Katz A.; Legge A.; Buchsbaum R.; Detyniecki K.; Psychiatric and behavioral side effects of antiepileptic drugs in adults with epilepsy. Epilepsy Behav 2017,76,24-31","journal-title":"Epilepsy Behav"},{"key":"ref=55","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2019.107402","volume":"204","author":"Sartori S.B.","year":"2019","unstructured":"Sartori S.B.; Singewald N.; Novel pharmacological targets in drug development for the treatment of anxiety and anxiety-related disorders. Pharmacol Ther 2019,204","journal-title":"Pharmacol Ther"},{"key":"ref=56","doi-asserted-by":"publisher","first-page":"3237","DOI":"10.2174\/1381612822666160311115226","volume":"22","author":"Sharma C.","year":"2016","unstructured":"Sharma C.; Al Kaabi J.M.; Nurulain S.M.; Goyal S.N.; Kamal M.A.; Ojha S.; Polypharmacological Properties and Therapeutic Potential of \u03b2-Caryophyllene: A Dietary Phytocannabinoid of Pharmaceutical Promise. Curr Pharm Des 2016,22(21),3237-3264","journal-title":"Curr Pharm Des"},{"key":"ref=57","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1177\/1091581816655303","volume":"35","author":"Schmitt D.","year":"2016","unstructured":"Schmitt D.; Levy R.; Carroll B.; Toxicological Evaluation of \u03b2-Caryophyllene Oil: Subchronic Toxicity in Rats. Int J Toxicol 2016,35(5),558-567","journal-title":"Int J Toxicol"},{"key":"ref=58","doi-asserted-by":"publisher","DOI":"10.1016\/j.fct.2019.110876","volume":"135","author":"Bastaki M.","year":"2020","unstructured":"Bastaki M.; Api A.M.; Aubanel M.; Bauter M.; Cachet T.; Demyttenaere J.C.R.; Diop M.M.; Harman C.L.; Hayashi S.M.; Krammer G.; Lu V.; Marone P.A.; Mendes O.; Renskers K.J.; Schnabel J.; Tsang S.Y.; Taylor S.V.; Dietary administration of \u03b2-caryophyllene and its epoxide to Sprague-Dawley rats for 90 days. Food Chem Toxicol 2020,135","journal-title":"Food Chem Toxicol"},{"key":"ref=59","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1111\/jnc.13833","volume":"139","author":"Tian X.","year":"2016","unstructured":"Tian X.; Peng J.; Zhong J.; Yang M.; Pang J.; Lou J.; Li M.; An R.; Zhang Q.; Xu L.; Dong Z.; \u03b2-Caryophyllene protects in\u00a0vitro neurovascular unit against oxygen-glucose deprivation and re-oxygenation-induced injury. J Neurochem 2016,139(5),757-768","journal-title":"J Neurochem"}],"container-title":["Current Molecular Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/eurekaselect.com\/article\/download\/181801","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/181801\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/eurekaselect.com\/article\/download\/181801","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,6]],"date-time":"2025-05-06T22:56:58Z","timestamp":1746572218000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/181801\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12,31]]},"references-count":59,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12,31]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1874467213666200510004622","relation":{},"ISSN":["1874-4672"],"issn-type":[{"value":"1874-4672","type":"print"}],"subject":[],"published":{"date-parts":[[2020,12,31]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2019-12-27","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-03-31","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-04-05","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-12-31","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}